A series of novel amidinourea derivatives was synthesized, and the compounds were evaluated as inhibitors of MDA‐MB‐231 human breast cancer cell proliferation. In addition, a second series of triazine derivatives designed as rigid congeners of the amidinoureas was synthesized, and the compounds were evaluated for their antiproliferative activity. Among the two series, amidinourea 3 d (N‐[N‐[8‐[[N‐
合成了一系列新型的mid
脲衍
生物,并将这些化合物作为
MDA-MB-231人乳腺癌细胞增殖的
抑制剂进行了评估。另外,合成了设计为the
脲脲的刚性同源物的第二系列的三嗪衍
生物,并评估了这些化合物的抗增殖活性。在这两个系列中,a
脲3 d(N- [ N- [8-[[ N-(
吗啉-4-羰基)
氨基甲酰
氨基]
氨基]辛基]
氨基甲酰
氨基]
吗啉-4-羧
酰胺出现了,是一种有效的抗癌化合物的IC 50值的0.76μ米,类似于
他莫昔芬的。